# Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis

> **NCT04318600** · PHASE1 · COMPLETED · sponsor: **Yan'an Affiliated Hospital of Kunming Medical University** · enrollment: 16 (actual)

## Conditions studied

- Lupus Nephritis
- Mesenchymal Stem Cells

## Interventions

- **DRUG:** human amniotic mesenchymal stem cell

## Key facts

- **NCT ID:** NCT04318600
- **Lead sponsor:** Yan'an Affiliated Hospital of Kunming Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2017-03-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04318600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04318600, "Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04318600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*